Distribution, blood transport, and degradation of antidiuretic hormone in man.

The distribution, blood transport, and metabolic clearance of physiological concentrations of antidiuretic hormone were studied in 10 hydrated normal subjects with radioiodinated arginine vasopressin (125I-AVP). At 37 degrees C no binding of 125I-AVP to plasma proteins could be demonstrated, but some metabolites were associated with plasma proteins. 125I-AVP was rapidly distributed into a space approximating the extracellular fluid volume. Metabolic breakdown products became demonstrable within minutes after injection. The mean metabolic clearance rate of 125I-AVP was 4.1 ml/min/kg and the mean plasma half-life 24.1 min. Renal clearance had a mean value of 80 ml/min and accounted for 27% of the total metabolic clearance. It is concluded that in man antidiuretic hormone circulates as a free (non-protein bound) peptide, diffuses readily into the extracellular fluid space, and is metabolized within minutes. A plasma half-life of 24 min is consistent with the duration of antidiuresis after hormone administration or release.

[1]  S. Glick,et al.  Radioimmunoassay of arginine vasopressin in human plasma. , 1973, The Journal of clinical endocrinology and metabolism.

[2]  S. Udenfriend,et al.  Fluorometric assay of proteins in the nanogram range. , 1973, Archives of biochemistry and biophysics.

[3]  J. Lee,et al.  The estimation of vasopressin in the blood and urine of hydrated and dehydrated subjects , 1963, The Journal of physiology.

[4]  G. Robertson,et al.  Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. , 1973, The Journal of clinical investigation.

[5]  M. Ginsburg.  The clearance of vasopressin from the splanchnic vascular area and the kidneys. , 1957, The Journal of endocrinology.

[6]  J. Lee,et al.  The renal clearance and plasma binding of vasopressin in the dog. , 1967, The Journal of endocrinology.

[7]  C. Fong,et al.  Disappearance of plasma radioactivity after injection of H3- or I-131-labeled arginine vasopressin. , 1961, Journal of applied physiology.

[8]  C. Kleeman,et al.  Relative potency of arginine-8-vasopressin and lysine-8-vasopressin in humans. , 1967, The Journal of laboratory and clinical medicine.

[9]  C. Kleeman,et al.  PHYSIOLOGIC STUDIES OF ANTIDIURETIC HORMONE BY ITS DIRECT MEASUREMENT IN HUMAN PLASMA. , 1964, The Journal of clinical investigation.

[10]  J. Roth,et al.  Immunoassay of plasma vasopressin in man. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. H. Bowman,et al.  Mechanism of inactivation of vasopressin and oxytocin by the isolated perfused rat kidney. , 1973, Endocrinology.

[12]  J. Roth,et al.  Monoiodo-oxytocin: Demonstration of Its Biological Activity and Specific Binding to Isolated Fat Cells , 1972 .

[13]  H. Burger,et al.  Metabolic clearance rate of radioiodinated human growth hormone in man. , 1969, The Journal of clinical investigation.

[14]  R. Guillemin,et al.  Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose. , 1959, Biochimica et biophysica acta.

[15]  H D Lauson,et al.  Metabolism of antidiuretic hormones. , 1967, The American journal of medicine.

[16]  C. Beardwell.  Radioimmunoassay of arginine vasopressin in human plasma. , 1971, The Journal of clinical endocrinology and metabolism.

[17]  W. J. O'connor.  The rôle of the neurohypophysis of the dog in determining urinary changes, and the antidiuretic activity of urine, following the administration of sodium chloride or urea. , 1950, Quarterly journal of experimental physiology and cognate medical sciences.

[18]  R. Schroeder,et al.  [On the determination and behavior of ADH in human plasma]. , 1959, Klinische Wochenschrift.

[19]  G. Rydén,et al.  Half-life of oxytocin andlysine-vasopressin in blood of rat at different hormonal stages , 1967 .

[20]  R. Walter,et al.  Differences in the enzymatic inactivation of arginine vasopressin and oxytocin by rat kidney homogenate. , 1975, Endocrinology.

[21]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[22]  N. Taylor,et al.  Antidiuretic substances in human urine after haemorrhage, fainting, dehydration and acceleration , 1953, The Journal of physiology.

[23]  D. Fisher,et al.  Radioimmunoassay measurement of arginine vasopressin in serum: development and application. , 1974, The Journal of clinical endocrinology and metabolism.

[24]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[25]  J. Dingman,et al.  Increased plasma arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids. , 1967, The Journal of clinical investigation.

[26]  S. Yoshida,et al.  METHOD FOR THE ASSAY OF ANTIDIURETIC HORMONE IN PLASMA WITH A NOTE ON THE ANTIDIURETIC TITER OF HUMAN PLASMA. , 1963, The Journal of laboratory and clinical medicine.

[27]  D. Rodbard,et al.  Polyacrylamide Gel Electrophoresis , 2004 .

[28]  C. Fong,et al.  ON THE MECHANISM OF ACTION OF THE ANTIDIURETIC HORMONE (VASOPRESSIN). , 1960, Proceedings of the National Academy of Sciences of the United States of America.